.

               Iridium Biosciences was established  by Vincent Ling, Ph.D.,          in 2009 , as a organization dedicated to servicing biotechnology     innovators.  Members of   Iridium Biosciences are independent  biotechnology professionals that have decades of experience plus documented track records of success in industrial settings:

     -  Small start-ups with precise goals for proof-of-concept,

      - Midsize biotechs elaborating on core technologies

      - Large pharma investigating new drug opportunities

    We provide individualized  strategies sculpted for your individual project needs.

   Satish Menon, Ph.D.,  Manufacturing and Process Development

   Cornelius Sobel, Ph.D.,  Clinical and Regulatory Affiars

   Eugene L. Brown, Ph.D., DNA Platform Technologies

   Chris Dippel,  Business Development

   Charlie Popkin, M.S., M.B.A., Financial Management

    Linda Lemieux, A.L.M.,  Regulatory Compliance, QA, QC

   Olufemi Adegbesan, Information Technology Systems

    Lisa Orecchio, M.S., Technical Sales and Services